Since 2009 Dr. Martin Stoddart has been working as a Principal Scientist at the AO Research Institute, where he is responsible for the Stem Cell Focus Area.
He completed his bachelor studies in Biology at the University of Aberystwyth in 1995. He then spent a year in Davos at ARI where he completed his M.Phil in Cartilage Biology. Between 1996–2000 he carried out his doctoral thesis at the University of Nottingham in the field of Cancer Angiogenesis. He then returned to Switzerland to work in the Laboratory for experimental cartilage research in Zürich, initially as Post-Doc and between 2003–2005 as Group Head. During that time, he also took a 6 month sabbatical at the Centre for Molecular Orthopeadics, Harvard Medical School, Brigham and Womens Hospital, Boston, to learn viral gene transfer techniques. In 2005 he returned to ARI.
His main focus is the use of autologous stem cells and gene transfer for the repair of musculoskeletal tissues using a cell therapy approach. To this aim he investigates novel cell identification and isolation methods. His research interests include the mechano-regulation of stem cell fate, in particular chondrogenic differentiation. He is also interested in the mechanisms by which stem cells direct cell fate and interact with endogenous cells to effect a repair.
He is the author of over 60 scientific papers, 10 book chapters and is the editor of the book, Mammalian Cell Viability Methods. Methods in Molecular Biology – Vol.740. He is the Chair of the Basic Science Education Committee of the ORS and an Editor for Tissue Engineering Journal Parts A, B, C. He is also a Scientific Editor for eCM Journal and an organiser of the yearly eCM Conference.